The trademark DICLOVAN was filed by VAN PHARMA B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on March 5, 2023, and received one opposition filed on May 31, 2023 by Novartis AG on Likelihood of confusion. the opponent was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued May 31, 2023
The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals and natural remedies
Medicines for human purposes
Drugs for medical purposes
Non-prescription medicines
Pharmaceutical preparations and substances such as medical creams, -gels, -tablets, -film-coated tablets, -powder for oral suspension and - powder for solution for intravenous injections
Capsules for medicines
Cachets for pharmaceutical purposes
Tinctures for medical purposes
Nutraceutical preparations for therapeutic or medical purposes